Venn Life Sciences Holdings (VENN)

 

VENN Share PerformanceMore

52 week high30.300 03/08/16
52 week low15.110 28/02/17
52 week change -4.500 (-20.93%)
4 week volume5,586,948 27/02/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Venn Life Sciences swings to FY pretax loss

Venn Life Sciences has swung to a FY pretax loss after what it described as another strong year. "We have started 2017 wit...

Final Results

RNS Number: 1499A Venn Life Sciences Holdings PLC 22 March 2017 22 March 2017 Venn Life Sciences Holdings Plc ("Venn" or the "Company") Final Results for the year ended 31 December 2016 Venn Life Sciences (AIM: VENN), a growing Contract Research Organisation (CRO) providing drug development, clinical trial management and resourcing solutions to...

Venn Life Sciences reports strong 2016 growth

Venn Life Sciences said 2016 represented another year of strong growth for the company with sales of more than 18m, fro...

Venn Life Sciences reports strong 2016 growth

Year End Update

RNS Number: 4096Y Venn Life Sciences Holdings PLC 03 March 2017 3 March 2017 Venn Life Sciences Holdings Plc ("Venn Life Sciences" or the "Company") Year End Update Venn Life Sciences (AIM: VENN), a growing Contract Research Organisation (CRO) providing drug development, clinical trial management and resourcing solutions to pharmaceutical, bio...

Venn Life Sciences completes Innovenn UK stake sale

Venn Life Sciences has completed the sale of its shareholding in Innovenn UK Ltd to Integumen Ltd and notes that compa...

Completion of Sale

RNS Number: 5204P Venn Life Sciences Holdings PLC 18 November 2016 Venn Life Sciences Holdings Plc ("Venn" or the "Company") Completion of Sale Venn Life Sciences (AIM: VENN), a growing Contract Research Organisation providing drug development, clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical devic...

REPLACEMENT - Contract win

RNS Number: 9217O Venn Life Sciences Holdings PLC 10 November 2016 The following amendment(s) have been made to the Venn Life Sciences Holdings plc - Contract Win announcement released on 8 November 2016 at 07:00 under RNS No 5443O. The correction relates to notification that the contract win is a related party transaction under the AIM Rules and E...

Equity Research (VENN)

Venn Life Sciences Holdings plc
22/03/2017
The growing Contract Research Organisation (CRO) providing drug development, clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device clients has...
Venn Life Sciences Holdings plc
08/11/2016
The growing Contract Research Organisation (CRO) providing drug development, clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device clients, has...
Venn Life Sciences Holdings plc
13/09/2016
Venn Life Sciences* (VENN.L) 28p £16.9m The growing Clinical Research Organisation providing clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device...

Latest discussion posts More

  • News: Integumen to IPO, and results

    A confusing set of results, with core EBITDA at first glance well below Hybridan's forecast for one? It would be useful to see an analyst report to identify any ...
    22-Mar-2017
    gretel
  • Venn

    Looks to me that this company is priced to fail, which seems unlikely. Positive update on 2016 sales and on-going momentum into 2017 suggest Venn is going places. I bought a ...
    6-Mar-2017
    conor00
  • Good trading update today

    with revenues bang on expectations for last year. And the business is evidently continuing to thrive given the 5.7m euros of orders already booked this year. The share price ...
    3-Mar-2017
    gretel

Users' HoldingsMore

Users who hold Venn Life Sciences Holdings also hold..
APC TECHNOLOGY23%
ROCKHOPPER17%
BT GROUP17%
AMINO TECH11%
REDSTONECON11%

Codes & Symbols

ISINGB00B9275X97
SymbolsVENN, LSE:VENN, VENN.L, VENN:LN, LON:VENN, XLON:VENN